Norris Healthcare Center 3 (HC3) — Los Angeles, California

Norris Healthcare Center 3 (HC3) is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Norris Healthcare Center 3 (HC3) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: BRAF V600E-mutant Metastatic Colorectal Cancer, Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Norris Healthcare Center 3 (HC3)?

Norris Healthcare Center 3 (HC3) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Norris Healthcare Center 3 (HC3) conducted?

Norris Healthcare Center 3 (HC3) has 2 clinical trials on record, with 1 currently active. Their work covers BRAF V600E-mutant Metastatic Colorectal Cancer, Breast Cancer.

Is Norris Healthcare Center 3 (HC3) accredited by Crixeo Health?

Norris Healthcare Center 3 (HC3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Norris Healthcare Center 3 (HC3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.